Ovarian Cancer Trial Result: Increased
capacity to engage in daily living activities
Over 25 cycles of HEATT® the mean Karnofsky
Performance Score improved from 94 to 98.
Karnofsky is a standard way of measuring the ability of cancer patients to perform ordinary tasks. Patients reported a baseline Karnofsky score, showing their ability to engage in minimum daily living activities.
For reference, the upper end of the Karnofsky scores refer to the following activities:
100 – Normal and healthy.
90 – Minor signs or symptoms of disease with little impact on patient functioning.
80 – Patient can carry on normal activities with effort.
70 – Patient can care for self but unable to carry on normal activity or to do active work.
The mean Karnofsky Performance Status score Pre-HEATT® therapy was 94. Post-HEATT®, the Karnofsky score increased to an average of 98. As testimonial data, patients reported being able to walk further without exerted effort, having a reduction in labored breathing, and experiencing an overall increase in energy. Karnofsky scores are related to survival, stated in much of the literature. The Karnofsky score being higher correlates to the greater the chance of survival, and it also suggests that patients with higher Karnofsky scores responded better to therapy. This significant finding from the study indicates that not only did patients live longer than expected, but also their ability to participate more fully in living was enhanced. The comparative graph shows the improvement in Karnofsky scores following HEATT®.